OrganoClick (ORGC) Q2 2026 earnings summary

Executive summary

• Operating profit improved significantly year-over-year, driven by cost reductions and a stronger gross margin despite a 26% drop in Q2 sales and a 24% drop for H1 2026.

• Strategic transition to a license-based model in Wood Protection and increased focus on consumer and nonwoven products.

• Rights issue raised SEK 33 million, strengthening the financial position and reducing debt.

Financial highlights

• Q2 net sales: SEK 22.1 million (down 26.3% year-over-year); H1 net sales: SEK 49.4 million (down 24.3%).

• Q2 EBIT: SEK -2.1 million (improved from -4.7 million); H1 EBIT: SEK -1.8 million (improved from -6.8 million).

• Q2 gross margin: 28.6% (up from 21.6%); H1 gross margin: 29.6% (up from 23.6%).

• Q2 EPS: SEK -0.04 (vs. -0.06); H1 EPS: SEK -0.05 (vs. -0.10).

• Cash flow from operating activities: SEK 1.8 million in Q2 (down from 7.7 million); SEK 1.5 million for H1 (up from -2.8 million).

Outlook and guidance

• Ongoing strategic shift to a pure green chemical company with a more scalable, license-based business model.

• Cost base to be reduced by SEK 13-14 million annually after full effect of restructuring.

• Focus on compensating for the loss of a major industrial customer and driving growth in consumer and nonwoven segments.